Steve E. Krognes
2019
In 2019, Steve E. Krognes earned a total compensation of $2.5M as Chief Financial Officer and Treasurer at Denali Therapeutics, a 37% decrease compared to previous year.
Compensation breakdown
| Bonus | $188,023 |
|---|---|
| Option Awards | $1,558,941 |
| Salary | $470,057 |
| Stock Awards | $305,830 |
| Other | $7,834 |
| Total | $2,530,685 |
Krognes received $1.6M in option awards, accounting for 62% of the total pay in 2019.
Krognes also received $188K in bonus, $470.1K in salary, $305.8K in stock awards and $7.8K in other compensation.
Rankings
In 2019, Steve E. Krognes' compensation ranked 4,800th out of 13,971 executives tracked by ExecPay. In other words, Krognes earned more than 65.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,800 out of 13,971 | 66th |
Division Manufacturing | 1,788 out of 5,701 | 69th |
Major group Chemicals And Allied Products | 621 out of 2,200 | 72nd |
Industry group Drugs | 523 out of 1,886 | 72nd |
Industry Biological Products, Except Diagnostic Substances | 114 out of 389 | 71st |
Source: SEC filing on April 22, 2020.
Krognes' colleagues
We found three more compensation records of executives who worked with Steve E. Krognes at Denali Therapeutics in 2019.
News
Denali Therapeutics CEO Ryan Watts' 2021 pay jumps 36% to $13M
April 19, 2022
Denali Therapeutics CEO Ryan Watts' 2020 pay jumps 87% to $9.3M
April 22, 2021
Denali Therapeutics CEO Ryan Watts' 2019 pay slips 17% to $5M
April 22, 2020
Denali Therapeutics CEO Ryan Watts' 2018 pay jumps 338% to $6M
April 18, 2019